SHARES of YSP Southeast Asia Bhd have gained momentum in recent weeks amid expectations that the generic drug manufacturer could see strong growth this year.
This comes following the company’s encouraging performance year to date amid improving prospects in the domestic market.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!